Sigrid Stabiliser launched at Kronans Apotek – making preventive health more accessible

Stockholm, February 5, 2025 – Sigrid Therapeutics announces today that their innovative product, Sigrid Stabiliser, which was previously only available through the company's own e-commerce, will now be launched and offered exclusively at Kronans Apotek starting in February 2025. The partnership means that a scientifically based and natural technology, SiPore®, which is used to control blood sugar levels and weight, is made available to a wider Swedish audience. This strengthens Sigrid's vision that no one should have to suffer from lifestyle diseases.

Innovative solution available for blood sugar and weight control
Professor Tore Bengtsson, an expert in physiology at Stockholm University, has developed the innovative, safe and patented SiPore® technology, which slows the breakdown of carbohydrates in the intestine. This in turn, like GLP-1 drugs, leads to more stable blood sugar, reduced sugar cravings and snacking, and contributes to weight loss. The technology has been shown to be both effective and safe by acting locally in the gastrointestinal tract without being absorbed by the body. Consumer surveys have shown that 93% feel fuller for longer, 89% report reduced sugar cravings between meals and 92% experience less bloating.

The importance of the collaboration with Kronans Apotek
The product Sigrid Stabiliser, based on the SiPore® technology, was successfully launched on the Swedish market via the company's own e-commerce in the spring of 2024 and sold out after just a couple of months. Now Sigrid Therapeutics is taking the next step through an exclusive partnership with Kronans Apotek, Sweden's largest pharmacy chain with an extensive e-commerce offering over 20,000 products. With the impressive reach and their strong focus on sustainable health solutions, Sigrid Stabiliser gets an optimal platform to make preventive health more accessible to Swedish consumers. This strategic partnership is an important milestone in Sigrid's endeavor to offer scientifically based and natural alternatives for blood sugar control and weight balance, and contributes to the company's vision that no one should have to suffer from lifestyle diseases.

Sana Alajmovic, CEO of Sigrid Therapeutics, comments:
"We are very pleased to collaborate with Kronans Apotek, which with its over 500 pharmacies and strong e-commerce has a unique reach in Sweden. This partnership represents a fantastic opportunity to make Sigrid Stabiliser available to more people looking for safe and sustainable solutions to control their blood sugar. We are convinced that this collaboration will be crucial in making preventive health an integral part of people's everyday lives."

Jörgen Bitzekis, E-com Director at Kronans Apotek, adds:
"We see a great need for products that not only treat but also prevent health problems. Including Sigrid Stabiliser in our range is an important step in making preventive health more accessible to our customers. We are both proud and happy to have been exclusively selected to offer such an innovative and groundbreaking solution for increased well-being."